Achieve Life Sciences, Inc. (ACHV)
NASDAQ: ACHV · Real-Time Price · USD
3.525
-0.305 (-7.96%)
At close: Jun 5, 2025, 4:00 PM
3.550
+0.025 (0.70%)
After-hours: Jun 5, 2025, 7:33 PM EDT
Achieve Life Sciences Employees
Achieve Life Sciences had 25 employees as of December 31, 2024. The number of employees increased by 3 or 13.64% compared to the previous year.
Employees
25
Change (1Y)
3
Growth (1Y)
13.64%
Revenue / Employee
n/a
Profits / Employee
-$1,846,400
Market Cap
122.26M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
| AbbVie | 55,000 |
ACHV News
- 2 days ago - Achieve Life Sciences: FDA Approval Not Assured, But Valuation Justifies Risk - Seeking Alpha
- 8 days ago - Achieve Life Sciences to Present at the Jefferies Global Healthcare Conference - GlobeNewsWire
- 16 days ago - Achieve Life Sciences to Present New Data at the 2025 ATS International Conference Demonstrating that Cytisinicline Reduced Cravings and Nicotine Intake - GlobeNewsWire
- 23 days ago - Achieve Life Sciences, Inc. (ACHV) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 23 days ago - Achieve Life Sciences Reports First Quarter 2025 Financial Results and Highlights Updates in Cytisinicline Program - GlobeNewsWire
- 4 weeks ago - Achieve Life Sciences to Announce First Quarter 2025 Financial Results and Host Conference Call and Webcast on May 13, 2025 - GlobeNewsWire
- 6 weeks ago - Achieve Life Sciences Announces Cytisinicline Phase 3 ORCA-3 Trial Publication on Smoking Cessation in JAMA Internal Medicine - GlobeNewsWire
- 3 months ago - Achieve Life Sciences, Inc. (ACHV) Q4 2024 Earnings Call Transcript - Seeking Alpha